161 related articles for article (PubMed ID: 22215203)
1. CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome.
Silveira VS; Canalle R; Scrideli CA; Queiroz RG; Lopes LF; Tone LG
Mol Cell Biochem; 2012 May; 364(1-2):217-23. PubMed ID: 22215203
[TBL] [Abstract][Full Text] [Related]
2. N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.
Kamel AM; Ebid GT; Moussa HS
Tumour Biol; 2015 Aug; 36(8):6341-8. PubMed ID: 25804798
[TBL] [Abstract][Full Text] [Related]
3. The impact of CYP3A5*3 on risk and prognosis in childhood acute lymphoblastic leukemia.
Borst L; Wallerek S; Dalhoff K; Rasmussen KK; Wesenberg F; Wehner PS; Schmiegelow K
Eur J Haematol; 2011 Jun; 86(6):477-83. PubMed ID: 21418106
[TBL] [Abstract][Full Text] [Related]
4. [Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia].
Gra OA; Glotov AS; Kozhekbaeva Zhm; Makarova OV; Nasedkina TV
Mol Biol (Mosk); 2008; 42(2):214-25. PubMed ID: 18610829
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia.
Hernández-González O; Ortiz-Zamudio JJ; Rodríguez-Pinal CJ; Alvarado-Morales I; Martínez-Jiménez VDC; Salazar-González RA; Correa-González LC; Gómez R; Portales-Pérez DP; Milán-Segovia RDC
Leuk Lymphoma; 2018 Aug; 59(8):1968-1975. PubMed ID: 29214875
[TBL] [Abstract][Full Text] [Related]
6. Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia.
Huang Z; Wang J; Qian J; Li Y; Xu Z; Chen M; Tong H
Mol Med Rep; 2017 Jun; 15(6):3493-3498. PubMed ID: 28440407
[TBL] [Abstract][Full Text] [Related]
7. Genetic variability in N-acetyltransferase 2 gene determines susceptibility to childhood lymphoid or myeloid leukemia in Brazil.
Zanrosso CW; Emerenciano M; Faro A; Gonçalves BA; Mansur MB; Pombo-de-Oliveira MS
Leuk Lymphoma; 2012 Feb; 53(2):323-7. PubMed ID: 21888617
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in CYP1B1, CYP3A5, GSTT1, and SULT1A1 Are Associated with Early Age Acute Leukemia.
Lopes BA; Emerenciano M; Gonçalves BA; Vieira TM; Rossini A; Pombo-de-Oliveira MS
PLoS One; 2015; 10(5):e0127308. PubMed ID: 25992585
[TBL] [Abstract][Full Text] [Related]
9. Relationship between NAT2 polymorphisms and onset risk of acute leukemia: a systematic review and meta-analysis.
Jiang WH; Wang XT; Zheng LD; Yan QQ; Chen LL
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9259-9266. PubMed ID: 31773677
[TBL] [Abstract][Full Text] [Related]
10. CYP3A5 ∗ 3 genetic polymorphism is associated with childhood acute lymphoblastic leukemia risk: A meta-analysis.
Ma LM; Liu HC; Ruan LH; Feng YM
Biomed J; 2015; 38(5):428-32. PubMed ID: 25673168
[TBL] [Abstract][Full Text] [Related]
11. Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia.
Canalle R; Silveira VS; Scrideli CA; Queiroz RG; Lopes LF; Tone LG
Leuk Lymphoma; 2011 Jun; 52(6):1118-26. PubMed ID: 21463130
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia.
Krajinovic M; Richer C; Sinnett H; Labuda D; Sinnett D
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):557-62. PubMed ID: 10868688
[TBL] [Abstract][Full Text] [Related]
13. The effect of race on the CYP3A-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia.
Sims RP
J Oncol Pharm Pract; 2016 Feb; 22(1):76-81. PubMed ID: 25305360
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia.
Ceppi F; Langlois-Pelletier C; Gagné V; Rousseau J; Ciolino C; De Lorenzo S; Kevin KM; Cijov D; Sallan SE; Silverman LB; Neuberg D; Kutok JL; Sinnett D; Laverdière C; Krajinovic M
Pharmacogenomics; 2014 Jun; 15(8):1105-16. PubMed ID: 25084203
[TBL] [Abstract][Full Text] [Related]
15. Childhood acute lymphoblastic leukemia: genetic determinants of susceptibility and disease outcome.
Krajinovic M; Labuda D; Sinnett D
Rev Environ Health; 2001; 16(4):263-79. PubMed ID: 12041882
[TBL] [Abstract][Full Text] [Related]
16. Influence of genetic polymorphisms of xenobiotic metabolizing enzymes on the risk of developing leukemia in a Tunisian population.
Ouerhani S; Nefzi MA; Menif S; Safra I; Douzi K; Fouzai C; Ben Ghorbel G; Ben Bahria I; Ben Ammar Elgaaied A; Abbes S
Bull Cancer; 2011 Dec; 98(12):95-106. PubMed ID: 22146408
[TBL] [Abstract][Full Text] [Related]
17. [Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province].
Liu QX; Chen HC; Liu XF; Cao YF; Zhang J; Liu J
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Dec; 26(12):975-9. PubMed ID: 16676594
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between the CYP3A5 genetic polymorphism and susceptibility to and prognosis of childhood acute leukemia].
Huang Z; Chai YH; Cen JN
Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):546-8. PubMed ID: 17953817
[No Abstract] [Full Text] [Related]
19. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia.
Canalle R; Burim RV; Tone LG; Takahashi CS
Environ Mol Mutagen; 2004; 43(2):100-9. PubMed ID: 14991750
[TBL] [Abstract][Full Text] [Related]
20. The Genetic Variants of IKZF1 Gene Linked with the Growing Risk of Childhood Acute Lymphoblastic Leukaemia.
Tayel SI; El-Hefnway SM; Abo El-Fotoh WMM; El-Zayat RS
Curr Mol Med; 2019; 19(1):32-39. PubMed ID: 30806315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
